Riot Games released a new Dev Update covering League of Legends gameplay balance, more ranked changes, and details on First ...

Microsoft has released ASP.NET Core in .NET 11 Preview 1, introducing new Blazor components like EnvironmentBoundary, Label, and DisplayName, along with relative URI navigation, QuickGrid row click ...

Exposure to the product "may cause temporary or medically reversible adverse health consequences," according to the FDA.

Timi is a news and deals writer who's been reporting on technology for over a decade. He loves breaking down complex subjects into easy-to-read pieces that keep you informed. But his recent passion ...

Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system ...

Google Warns Over 1 Billion Android Phones Are Now at Risk Your email has been sent If you’re using an older Android phone, Google has a message you probably don’t want to hear. More than 40% of ...

The FDA has updated the safety labeling for axicabtagene ciloleucel (Yescarta, Kite Oncology) ­— a CAR T-cell therapy — extending its indication to include patients with relapsed or refractory primary ...

WASHINGTON, D.C. — Diabetes patients who use certain TRUE METRIX blood glucose meters are being urged to review updated safety instructions after manufacturer ...

The FDA has updated the product labeling of capecitabine (Xeloda, Genentech) and fluorouracil to reflect the risks of acute toxicity and potentially fatal adverse reactions in patients with ...

FDA strengthens capecitabine and 5‑FU labels: DPD deficiency can trigger fatal toxicity; consider testing, lower doses, and prompt antidote. The FDA has updated the safety labeling for the ...

Amgen Inc (NASDAQ: AMGN) reported better-than-expected fourth-quarter revenues and earnings, while witnessing "strength across key drivers (Repatha, Uplizna), even before the full impact of recent ...

The U.S. Food and Drug Administration (FDA) has updated the warning label for the Depo-Provera birth control shot to include information about the risk of meningioma brain tumors. The label update is ...